Freelance science journalist, covering drugs, clinical trials, biotech, pharma and more. Writes for Nature, The Lancet, The New Scientist, and others.

Search Tweets

Twitter Feed

@AsherMullard — 545 followers, 208 tweets

Jul 13, 2017

The Economics of Indication-Based Drug Pricing: higher drug utilization, higher overall spending, higher profits  http://www.nejm.org/doi/full/10.1056/NEJMp1705035 

Jul 13, 2017

Time to move Alzheimer prevention trials even earlier in disease course, up to 25 years before onset, says Bateman  https://www.nature.com/news/stop-alzheimer-s-before-it-starts-1.22274 

Jul 06, 2017

RT @AndyBiotech: Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both  http://www.nejm.org/doi/full/10.1056/NEJMra1510062#.WV1UZelYP7M.twitter  by FDA's Janet Wo…

Show more